Mark Coleman, Director at Axsome Therapeutics, Inc. (AXSM), bought 16,200 shares at $23.10 ($374K) on 2019-06-26, disclosed to the SEC on 2019-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.25 | 400 | $9K | 2.5% |
| 2 | $23.10 | 15,800 | $365K | 97.5% |
| Total | $23.10 avg | 16,200 | $374K | 100% |
| Filing → |
| AXSM | SELL | 2026-02-27 | $4.0M | — | Filing → |
| AXSM | BUY | 2025-09-09 | $263K | — | Filing → |
| AXSM | SELL | 2025-05-29 | $1.6M | — | Filing → |